News on Hepatitis continually updated from thousands of sources around the net.
1 hr ago | Mental Help Net
A vaccine that protects children against four strains of flu may be more effective than the usual three-strain vaccine, a new study suggests.
Is racial profiling justified?
What's the best route to energy independence?
5 hrs ago | WVIZ-TV Cleveland
Hepatitis C is a nasty disease that can lie dormant for years before attacking the liver.
7 hrs ago | GastroHep.com
January's issue of the Alimentary Pharmacology & Therapeutics examines the use of nucleos ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.
11 hrs ago | News and Star
By working alongside the Unity Drug & Alcohol Recovery Service, she hopes that the weekly clinic will be more accessible for people who would like to start treatment or would like a discussion about it.
The biggest U.S. drug benefits manager plans to start a price war over a new generation of hepatitis C treatments that will cost $1,000 a pill, in a bid to drive down spending on the medicines.
Positive phase III results have been reported for an investigational three direct-acting-antiviral regimen plus ribavirin in patients with chronic genotype-1 hepatitis C virus infection.
The latest drug approved by the FDA to treat hepatitis C opens up new and much-needed treatment options.
Enanta Pharmaceuticals, Inc. today announced results from the SAPPHIRE-II study, the second of six phase 3 registrational studies being conducted by AbbVie for the treatment of hepatitis C virus genotype 1 infection, using a regimen containing Enanta's lead protease inhibitor ABT-450.
Hepatitis C is one of the most common chronic blood-borne infections in the United States, with more than 3 million people infected.
In a few days, doctors in Louisiana will start prescribing a new medicine being called a breakthrough for people with hepatitis C. And a Denham Springs man was in the clinical trial and was one of the first to possibly be cured.
Dec. 9, 2013 -- Experts call two new drugs for hepatitis C ''game changers" that they expect will dramatically improve treatment for many of the 3 million Americans with a chronic infection.
A discussion about the risk of transmitting or contracting HIV without mentioning Hepatitis C is like talking about Clyde Barrow without Bonnie Parker.
Sovaldi is the second drug approved by the FDA in the past two weeks to treat chronic HCV infection.
Health officials in the United States have approved a highly anticipated hepatitis C drug that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
The most recent issue of the Alimentary Pharmacology & Therapeutics compares the effectiveness of the hepatitis C virus protease inhibitors boceprevir vs telaprevir in a large cohort in the USA.
KosAbility is a Sunday afternoon community series by volunteer diarists, as a gathering for people living with disabilities, who love someone with a disability, or who want to know more about the issues.